Bevacizumab/IrinotecanLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2024卷 / 1期

关键词：

D O I：

10.1007/s40278-024-66073-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：91 / 91

相关论文

共 50 条

[1] Bevacizumab/capecitabine/irinotecanLack of efficacy in metastatic rectal adenocarcinoma: case report
Reactions Weekly, 2021, 1851 (1) : 82 - 82
[2] Etoposide/irinotecanLack of efficacy: case report
Reactions Weekly, 2022, 1927 (1) : 259 - 259
[3] Carboplatin/irinotecanLack of efficacy: case report
Reactions Weekly, 2021, 1866 (1) : 114 - 114
[4] Cisplatin/irinotecanLack of efficacy: case report
Reactions Weekly, 2022, 1913 (1) : 146 - 146
[5] Fluorouracil/Folinic-acid/IrinotecanLack of efficacy: case report
Reactions Weekly, 2025, 2043 (1) : 169 - 169
[6] Carboplatin/etoposide-phosphate/irinotecanLack of efficacy and haematological toxicity: case report
Reactions Weekly, 2024, 2027 (1) : 116 - 116
[7] Bevacizumab/paclitaxelLack of efficacy: case report
Reactions Weekly, 2024, 2035 (1) : 113 - 113
[8] Bevacizumab/temozolomideLack of efficacy: case report
Reactions Weekly, 2023, 1974 (1) : 80 - 80
[9] Bevacizumab/ifosfamideLack of efficacy: case report
Reactions Weekly, 2023, 1967 (1) : 96 - 96
[10] Bevacizumab/paclitaxelLack of efficacy: case report
Reactions Weekly, 2023, 1952 (1) : 105 - 105

← 1 2 3 4 5 →